SEC Form S-1 filed by QT Imaging Holdings Inc.
$QTI
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QTI") a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce the release of a machine learning-enabled image interpolation algorithm designed to significantly reduce scan times by approximately 50%. This advancement is expected to enhance patient comfort by decreasing time spent on the scanner and improve operational efficiency by increasing the number of patients scanned within a given timeframe. The advanced machine learning algorithm enables sophisticated image interpolation, allowing the system to skip every other scan level while accurately preserving high imag
QT Imaging Holdings, Inc. (NASDAQ:QTI) (the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce strengthening of its financials, by clearing its short-term liabilities and by forecasting solid revenue growth in 2025 and 2026. The Company announced amendments to both its convertible promissory note with YA II PN, Ltd. (the "YA Investor," and such promissory note, the "YA Note") and to its convertible promissory note with Funicular Funds, LP (the "Cable Car Investor," and such promissory note, the "Cable Car Note"), each of which was entered into on January 9, 2025. With the amendments of YA
QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce expansion of locations offering the Breast Acoustic CTTM Scanner to Couri Center for Gynecology and Integrative Women's Health, in Peoria, IL. The shipment was made together with our strategic business and distribution partner, NXC Imaging, Inc. "Our partnership with QTI marks a pivotal moment in breast imaging technology. With the QTI Breast Acoustic CTTM System, patients can experience an enhanced approach to breast imaging that prioritizes comfort and safety without compromising image quality," stated Jon Stoa,
S-8 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
EFFECT - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
424B3 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
Generated Scanner Sales Revenue of $1.4M with 56% Gross Margin in the First Quarter of 2024, Since the Company Became Public on March 4th Streamlined Business Model via Strategic Sales and Distribution Partnership in USA Reported in Academic Radiology the Results of a Second Blinded Screening Trial That Found That QTI Technology Is Similarly Effective as Digital Breast Tomosynthesis (DBT) or 3D Mammography Company Completed Merger with GigCapital5 QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first qu
Generated Scanner Sales Revenue of $0.9 Million with 65% Gross Margin in the Third Quarter of 2024 The Company Successfully Completed the Engineering and Clinical Feasibility Study with its Strategic Partner The Company Announced Entering into Favorable Amendments to Its $10 Million Convertible Promissory Note with YA II PN, Ltd. The Company Announced Insiders PIPE investment of $2.56 Million, fully funded by the QTI Board of Directors members and their Affiliates QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results
Generated Scanner Sales Revenue of $1.7 Million with 51% Gross Margin in the Second Quarter of 2024 The Company Continues to Make Progress in the Engineering and Clinical Feasibility Study with its Strategic Partner Signed a U.S. Exclusive Distribution Agreement Announced Partnership with the University of Oklahoma and OU Health Stephenson Cancer Center to Improve Precision in Cancer Detection and Treatment QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. "QT Imaging's team comp
SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)
SC 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)
SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)